DCF — LOGAN HEALTH WHITEFISH
Enterprise Value: $126.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$126.4M
Enterprise Value
$34.7M
PV of Cash Flows
$91.7M
PV of Terminal Value
$147.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $104.8M | $15.0M | 14.0% | $7.4M | $6.8M |
| Year 2 | $108.0M | $16.5M | 15.0% | $8.5M | $7.0M |
| Year 3 | $111.2M | $18.1M | 16.0% | $9.6M | $7.2M |
| Year 4 | $114.6M | $19.2M | 17.0% | $10.3M | $7.0M |
| Year 5 | $118.0M | $20.1M | 17.0% | $10.8M | $6.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $126.4M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$101.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1377236096221319
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5